Is the worst ETF of 2016 about to get even worse?
February 16, 2016 at 13:33 PM EST
The SPDR S&P biotech ETF — XBI — has plunged more than 30 percent year to date, and traders say the volatility isn't ending any time soon.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.